Tracking metabolic brain changes among patients with GRN disease can be useful for monitoring the disease's early stages before structural damage occurs.
Treatment with golimumab in a patient with psoriasis arthritis with a prior episode of undiagnosed CNS demyelination was associated with severe atypical optic neuritis.
Cardiovascular risk among patients with narcolepsy should be considered when implementing strategies and treatment decisions for this patient population.
Multiple clinical and electroencephalogram characteristics may independently predict antiseizure medication resistance in patients with idiopathic generalized epilepsy.